Get Involved
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
Study Purpose
This randomized phase II trial studies how well pazopanib hydrochloride works in treating patients with carcinoid tumors that are growing, spreading, or getting worse. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruitment Criteria
|
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms |
No |
|
Study Type
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies. |
Interventional |
| Eligible Ages | 18 Years and Over |
| Gender | All |
Inclusion Criteria:
- - Low- or intermediate-grade neuroendocrine carcinoma, including the following subtypes: carcinoid tumor, low- to intermediate-grade or well- to moderately-differentiated neuroendocrine carcinoma or tumor, atypical carcinoid tumor; documentation from a primary tumor or metastatic site is sufficient; patients with poorly differentiated neuroendocrine carcinoma, high-grade neuroendocrine carcinoma, adenocarcinoid tumor, or goblet cell carcinoid tumor are not eligible.
- - Locally unresectable or metastatic carcinoid tumors.
- - Patients must have histologic documentation or clinical evidence of a carcinoid tumor of primary site (including foregut, midgut, hindgut or other non-pancreatic site); tumors of unknown primary site are eligible provided the treating physician does not suspect medullary thyroid cancer, pancreatic neuroendocrine tumor, paraganglioma, or pheochromocytoma; unknown primary tumors will be classified as small bowel tumors for the purpose of stratification; functional (associated with a clinical syndrome) or nonfunctional tumors are allowed; target lesions must have shown disease progression if therapy included peptide receptor radiotherapy (PRRT) and PRRT must be completed at least 8 weeks prior to registration.
- - Radiological evidence for progressive disease (measurable or non-measurable) within 12 months prior to registration; patients who have received anti-tumor therapy during the past 12 months (including octreotide analogs) must have had radiological documentation of progression of disease while on or after receiving therapy.
- - No known endobronchial lesions and/or lesions infiltrating major pulmonary vessels that increase the risk of pulmonary hemorrhage; patients with lesions infiltrating major pulmonary vessels (contiguous tumor and vessels) are excluded; however, the presence of a tumor that is touching, but not infiltrating (abutting) the vessels is acceptable (computed tomography [CT] with contrast is strongly recommended to evaluate such lesions); patients with large protruding endobronchial lesions in the main or lobar bronchi are excluded; however, endobronchial lesions in the segmented bronchi are allowed.
- - Patients must have measurable disease per RECIST 1.1 by computed tomography (CT) scan or magnetic resonance imaging (MRI); lesions must be accurately measured in at least one dimension (longest diameter to be recorded) as >= 1 cm with CT or MRI (or >= 1.5 cm for lymph nodes); index lesions for the purpose of RECIST 1.1 measurements will not be selected from within the radiation therapy treatment field; however, if there is evidence of disease progression within the radiation treatment field, measurement of the progressing lesions will be documented.
- - No prior treatment with an inhibitor of vascular endothelial growth factor (VEGF) or vascular endothelial growth factor receptor (VEGFR) - Prior treatment (somatostatin analogs excepted) must be completed at least 2 weeks prior to registration; in addition, prior treatment (somatostatin analogs excepted) must be completed at least 4 weeks prior to initiation of study drug; treatment-related toxicities must have improved to =< grade 1 prior to registration, with the exception of alopecia.
- - Concurrent use of somatostatin analogs (SSTa) is allowed, provided that the patient is on a stable dose for at least two months and progressive disease on somatostatin analog has been documented; progression on octreotide is required for patients with tumors arising in the midgut.
- - Prior treatment with embolization (including bland embolization, chemoembolization, and selective internal radiation therapy) or ablative therapies is allowed if measurable disease remains outside of the treated area or there is documented disease progression in a treated site; there is no limit on the prior number of procedures; prior liver-directed or other ablative treatment must be completed at least 8 weeks prior to registration; index lesions for the purpose of RECIST 1.1 measurements will not be selected from within the radiation therapy treatment field; however, if there is evidence of disease progression within the radiation treatment field, measurement of the progressing lesions will be documented.
- - Patients should have completed any major surgery >= 4 weeks prior to registration and must have completed any minor surgery >= 2 weeks prior to registration; patients must have fully recovered from the procedure.
- - The following are examples of procedures considered to be minor: port placement, laparoscopy, thoracoscopy, bronchoscopy, mediastinoscopy, skin biopsies, incisional biopsies, imaging-guided biopsy for diagnostic purposes, and dental extraction procedures.
- - Insertion of a vascular access device, thoracentesis, paracentesis, and endoscopic ultrasonographic procedures are not considered to be major or minor surgeries.
- - No concurrent condition resulting in immune compromise, including chronic treatment with corticosteroids or other immunosuppressive agents.
- - No clinical evidence of central nervous system (CNS) metastases (including carcinomatous meningitis) at baseline, with the exception of those patients who have previously-treated CNS metastases (surgery +/- radiotherapy, radiosurgery, or gamma knife) and who meet both of the following criteria: a) are asymptomatic and b) had no requirement for steroids or enzyme-inducing anticonvulsants within 6 months prior to registration.
- - No history of abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess within 28 days prior to registration.
- - No clinically significant gastrointestinal abnormalities that may increase the risk for gastrointestinal bleeding within 28 days prior to registration including, but not limited to: - Active peptic ulcer.
- - Known endoluminal metastatic lesion(s) with history of bleeding.
- - Inflammatory bowel disease (e.g. ulcerative colitis, Crohn's disease), or other gastrointestinal conditions with increased risk of perforation.
- - No history of serious (i.e., requiring active medical therapy with medication or medical device under the supervision of a physician) non-healing wound, ulcer, trauma, or bone fracture within 28 days prior to study entry.
- - Patients with a history of hypertension must have blood pressure that is adequately controlled on antihypertensives; (< 140/90 mm Hg) - No symptomatic congestive heart failure (New York Heart Association class II, III, or IV) within 6 months prior to registration.
- - No arterial thrombotic events within 6 months of registration, including transient ischemic attack (TIA), cerebrovascular accident (CVA), peripheral arterial thrombus, myocardial infarction (MI), or unstable angina or angina requiring surgical or medical intervention in 6 months prior to registration; patients with clinically significant peripheral artery disease (i.e., claudication on less than one block) are ineligible; patients who have experienced a deep venous thrombosis or pulmonary embolus within 6 months prior to registration must be on stable therapeutic anticoagulation for at least 6 weeks prior to enrollment of this study.
- - Patients on therapeutic anticoagulation with low molecular weight heparins, fondaparinux, rivaroxaban or warfarin are eligible, provided that they are on a stable dose of anticoagulants; patients who are currently receiving antiplatelet therapy of prasugrel or clopidogrel or antiaggregation agents (e.g., eptifibatide, epoprostenol, dipyridamole) or low doses of acetylsalicylic acid (up to 100 mg daily) are also eligible.
- - No ongoing cardiac dysrhythmias, atrial fibrillation, or prolongation of corrected QT (QTc) interval to > 480 msec.
- - No evidence of active bleeding, bleeding diathesis, or hemoptysis (>= 1/2 teaspoon of red blood) within 8 weeks prior to registration.
- - No currently unstable angina and/or uncontrolled cardiac arrhythmias.
- - Patients with symptomatic peripheral vascular disease are ineligible.
- - Ejection fraction on echocardiogram (Echo) or multi gated acquisition scan (MUGA) > 50% - Chronic concomitant treatment with strong inhibitors of cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) is not allowed on this trial; patients on strong CYP3A4 inhibitors must discontinue the drug 14 days prior to the start of study treatment.
- - Women must not be pregnant or nursing; women of child bearing potential must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of human chorionic gonadotropin [HCG]) within 72 hours prior to registration; women of child-bearing potential include any female who has experienced menarche and who has not undergone surgical sterilization (hysterectomy, bilateral tubal ligation or bilateral oophorectomy) or is not postmenopausal (defined as amenorrhea >= 12 consecutive months; or women on hormone replacement therapy [HRT] with documented serum follicle stimulating hormone [FSH] level > 35 mIU/mL) - Age >= 18 years of age.
- - Eastern Cooperative Oncology Group (ECOG) performance status 0-1.
- - Granulocytes >= 1,500/mcL.
- - Platelets >= 100,000/mcL.
- - International normalized ratio (INR) =< 1.2 X upper limit of normal (ULN); only required for patients receiving anticoagulant therapy; patients are eligible if their INR is stable and within the recommended range for the desired level of anticoagulation.
- - QTc =< 480 msecs.
- - Thyroid stimulating hormone (TSH) within normal limits (WNL); medications for thyroid dysfunction are allowed as long as TSH is normal at registration; in patients with abnormal TSH, if the free thyroxine (free T4) and free thyroxine index (FTI) are normal and patient is clinically euthyroid, patient is eligible.
- - Bilirubin =< 1.5 x ULN.
- - Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) & alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x ULN; concomitant elevations in bilirubin and AST/ALT above 1.0 X ULN are NOT permitted; also, if liver metastases are present, AST & ALT =< 5 x ULN is allowed.
- - Serum creatinine =< 1.5 x ULN.
Trial Details
|
Trial ID:
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries. |
NCT01841736 |
|
Phase
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use. |
Phase 2 |
|
Lead Sponsor
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data. |
National Cancer Institute (NCI) |
|
Principal Investigator
The person who is responsible for the scientific and technical direction of the entire clinical study. |
Emily K Bergsland |
| Principal Investigator Affiliation | Alliance for Clinical Trials in Oncology |
|
Agency Class
Category of organization(s) involved as sponsor (and collaborator) supporting the trial. |
NIH |
| Overall Status | Active, not recruiting |
| Countries | Canada, United States |
|
Conditions
The disease, disorder, syndrome, illness, or injury that is being studied. |
Foregut Neuroendocrine Tumor, Hindgut Neuroendocrine Tumor, Metastatic Digestive System Neuroendocrine Tumor G1, Metastatic Neuroendocrine Tumor, Midgut Neuroendocrine Tumor G1, Neuroendocrine Tumor G2, Recurrent Digestive System Neuroendocrine Tumor G1, Regional Digestive System Neuroendocrine Tumor G1 |
PRIMARY OBJECTIVE:
- I. For patients with progressive carcinoid tumors, progression-free survival (PFS defined by central review according to Response Evaluation Criteria in Solid Tumors [RECIST] 1.1) will be compared between patients randomized to treatment with pazopanib (pazopanib hydrochloride) versus placebo.
- I. Overall survival (OS) will be compared between treatment arms.
- II. Objective response rate, duration of response, and time to treatment failure will be compared between treatment arms.
- III. Progression free survival (PFS) as assessed by central radiology review and local radiology review will be compared overall and within treatment arms.
- IV. Safety and tolerability of treatment with pazopanib/placebo will be evaluated within each treatment arm.
- V. PFS and other indicators of efficacy will be estimated in patients who crossover to pazopanib from placebo.
- VI. To determine the turn-around time for timely adjudicated central review.
- VII. To characterize the nature of discordance between local and central radiology review in assessment of progression.
- VIII. To characterize the type and rate of progression in carcinoid (at study entry, on-study, and at progression).
- IX. To develop new methods for modeling carcinoid growth and detecting treatment effects, and to perform simulations that advance new clinical trial designs to apply to future trials of carcinoid therapeutics.
- X. To assess for differences in quality of life (QOL)-related domains between the two treatment groups (pazopanib versus placebo).
- I. PFS at 6 months will be estimated within each treatment arm.
- II. Biochemical response (for chromogranin A, defined as a decrease of 50% or more in chromogranin A levels from baseline and for 5-hydroxyindoleacetic acid [5-HIAA], defined as a decrease of 50% or more in urinary 5-HIAA levels from baseline) will be compared between treatment arms among patients with elevated baseline levels of chromogranin A (CGA) and 5-HIAA.
- I. Patients undergo ECHO or MUGA during screening.
Arms
Experimental: Arm I (pazopanib hydrochloride)
Patients receive pazopanib hydrochloride PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo ECHO or MUGA during screening. Patients also undergo CT, MRI, and chest x-ray throughout the trial. Patients may optionally undergo blood sample collection during screening and on study.
Placebo Comparator: Arm II (placebo)
Patients receive placebo PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. At the time of progressive disease, patients may cross-over to Arm I. Patients undergo ECHO or MUGA during screening. Patients also undergo CT, MRI, and chest x-ray throughout the trial. Patients may optionally undergo blood sample collection during screening and on study.
Interventions
Procedure: - Biospecimen Collection
Undergo blood sample collection
Procedure: - Computed Tomography
Undergo CT
Procedure: - Echocardiography Test
Undergo ECHO
Other: - Laboratory Biomarker Analysis
Correlative studies
Procedure: - Magnetic Resonance Imaging
Undergo MRI
Procedure: - Multigated Acquisition Scan
Undergo MUGA
Drug: - Pazopanib Hydrochloride
Given PO
Other: - Placebo Administration
Given PO
Other: - Quality-of-Life Assessment
Ancillary studies
Procedure: - X-Ray Imaging
Undergo chest x-ray
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Status
Address
Alaska Breast Care and Surgery LLC
Anchorage, Alaska, 99508
Status
Address
Alaska Women's Cancer Care
Anchorage, Alaska, 99508
Status
Address
Anchorage Oncology Centre
Anchorage, Alaska, 99508
Status
Address
Katmai Oncology Group
Anchorage, Alaska, 99508
Status
Address
Providence Alaska Medical Center
Anchorage, Alaska, 99508
Status
Address
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259
Status
Address
Kaiser Permanente-Anaheim
Anaheim, California, 92806
Status
Address
Kaiser Permanente-Baldwin Park
Baldwin Park, California, 91706
Status
Address
Kaiser Permanente-Fontana
Fontana, California, 92335
Status
Address
Kaiser Permanente South Bay
Harbor City, California, 90710
Status
Address
Kaiser Permanente-Irvine
Irvine, California, 92618
Status
Address
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, 90027
Status
Address
Los Angeles General Medical Center
Los Angeles, California, 90033
Status
Address
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033
Status
Address
Kaiser Permanente West Los Angeles
Los Angeles, California, 90034
Status
Address
Cedars Sinai Medical Center
Los Angeles, California, 90048
Status
Address
Palo Alto Medical Foundation Health Care
Palo Alto, California, 94301
Status
Address
Stanford Cancer Institute Palo Alto
Palo Alto, California, 94304
Status
Address
Kaiser Permanente - Panorama City
Panorama City, California, 91402
Status
Address
Kaiser Permanente-Riverside
Riverside, California, 92505
Status
Address
Kaiser Permanente-San Diego Mission
San Diego, California, 92108
Status
Address
Kaiser Permanente-San Diego Zion
San Diego, California, 92120
Status
Address
UCSF Medical Center-Mount Zion
San Francisco, California, 94115
Status
Address
UCSF Medical Center-Mission Bay
San Francisco, California, 94158
Status
Address
Kaiser Permanente-San Marcos
San Marcos, California, 92078
Status
Address
Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California, 95065
Status
Address
Palo Alto Medical Foundation-Sunnyvale
Sunnyvale, California, 94086
Status
Address
Kaiser Permanente-Woodland Hills
Woodland Hills, California, 91367
Status
Address
The Medical Center of Aurora
Aurora, Colorado, 80012
Status
Address
Boulder Community Hospital
Boulder, Colorado, 80301
Status
Address
Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, 80304
Status
Address
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, 80907
Status
Address
Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, 80907
Status
Address
AdventHealth Porter
Denver, Colorado, 80210
Status
Address
Colorado Blood Cancer Institute
Denver, Colorado, 80218
Status
Address
Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, 80218
Status
Address
Rocky Mountain Cancer Centers-Midtown
Denver, Colorado, 80218
Status
Address
Saint Joseph Hospital - Cancer Centers of Colorado
Denver, Colorado, 80218
Status
Address
Rocky Mountain Cancer Centers-Rose
Denver, Colorado, 80220
Status
Address
Rose Medical Center
Denver, Colorado, 80220
Status
Address
Western States Cancer Research NCORP
Denver, Colorado, 80222
Status
Address
Mercy Medical Center
Durango, Colorado, 81301
Status
Address
Mountain Blue Cancer Care Center - Swedish
Englewood, Colorado, 80113
Status
Address
Swedish Medical Center
Englewood, Colorado, 80113
Status
Address
Poudre Valley Hospital
Fort Collins, Colorado, 80524
Status
Address
Mountain Blue Cancer Care Center
Golden, Colorado, 80401
Status
Address
Banner North Colorado Medical Center
Greeley, Colorado, 80631
Status
Address
Rocky Mountain Cancer Centers-Greenwood Village
Greenwood Village, Colorado, 80111
Status
Address
Rocky Mountain Cancer Centers-Lakewood
Lakewood, Colorado, 80228
Status
Address
Saint Anthony Hospital
Lakewood, Colorado, 80228
Status
Address
AdventHealth Littleton
Littleton, Colorado, 80122
Status
Address
Rocky Mountain Cancer Centers-Sky Ridge
Lone Tree, Colorado, 80124
Status
Address
Sky Ridge Medical Center
Lone Tree, Colorado, 80124
Status
Address
Longmont United Hospital
Longmont, Colorado, 80501
Status
Address
Rocky Mountain Cancer Centers-Longmont
Longmont, Colorado, 80501
Status
Address
Banner McKee Medical Center
Loveland, Colorado, 80539
Status
Address
AdventHealth Parker
Parker, Colorado, 80138
Status
Address
Rocky Mountain Cancer Centers-Parker
Parker, Colorado, 80138
Status
Address
Saint Mary Corwin Medical Center
Pueblo, Colorado, 81004
Status
Address
Rocky Mountain Cancer Centers - Pueblo
Pueblo, Colorado, 81008
Status
Address
Intermountain Health Lutheran Hospital
Wheat Ridge, Colorado, 80401
Status
Address
Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, 06105
Status
Address
Beebe Medical Center
Lewes, Delaware, 19958
Status
Address
Delaware Clinical and Laboratory Physicians PA
Newark, Delaware, 19713
Status
Address
Helen F Graham Cancer Center
Newark, Delaware, 19713
Status
Address
Medical Oncology Hematology Consultants PA
Newark, Delaware, 19713
Status
Address
Christiana Care Health System-Christiana Hospital
Newark, Delaware, 19718
Status
Address
Beebe Health Campus
Rehoboth Beach, Delaware, 19971
Status
Address
TidalHealth Nanticoke / Allen Cancer Center
Seaford, Delaware, 19973
Status
Address
Christiana Care Health System-Wilmington Hospital
Wilmington, Delaware, 19801
Status
Address
Moffitt Cancer Center
Tampa, Florida, 33612
Status
Address
John B Amos Cancer Center
Columbus, Georgia, 31904
Status
Address
Memorial Health University Medical Center
Savannah, Georgia, 31404
Status
Address
Pali Momi Medical Center
'Aiea, Hawaii, 96701
Status
Address
Queen's Cancer Center - Pearlridge
'Aiea, Hawaii, 96701
Status
Address
Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu, Hawaii, 96813
Status
Address
Queen's Medical Center
Honolulu, Hawaii, 96813
Status
Address
Straub Clinic and Hospital
Honolulu, Hawaii, 96813
Status
Address
University of Hawaii Cancer Center
Honolulu, Hawaii, 96813
Status
Address
Hawaii Cancer Care Inc-Liliha
Honolulu, Hawaii, 96817
Status
Address
Queen's Cancer Center - Kuakini
Honolulu, Hawaii, 96817
Status
Address
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96826
Status
Address
Castle Medical Center
Kailua, Hawaii, 96734
Status
Address
Wilcox Memorial Hospital and Kauai Medical Clinic
Lihue, Hawaii, 96766
Status
Address
Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, 83706
Status
Address
Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, 83854
Status
Address
Illinois CancerCare-Bloomington
Bloomington, Illinois, 61704
Status
Address
Illinois CancerCare-Canton
Canton, Illinois, 61520
Status
Address
Illinois CancerCare-Carthage
Carthage, Illinois, 62321
Status
Address
Northwestern University
Chicago, Illinois, 60611
Status
Address
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637
Status
Address
Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, 62526
Status
Address
Decatur Memorial Hospital
Decatur, Illinois, 62526
Status
Address
Illinois CancerCare-Eureka
Eureka, Illinois, 61530
Status
Address
Illinois CancerCare-Galesburg
Galesburg, Illinois, 61401
Status
Address
Ingalls Memorial Hospital
Harvey, Illinois, 60426
Status
Address
Illinois CancerCare-Kewanee Clinic
Kewanee, Illinois, 61443
Status
Address
Illinois CancerCare-Macomb
Macomb, Illinois, 61455
Status
Address
Loyola University Medical Center
Maywood, Illinois, 60153
Status
Address
SSM Health Good Samaritan
Mount Vernon, Illinois, 62864
Status
Address
Illinois CancerCare-Ottawa Clinic
Ottawa, Illinois, 61350
Status
Address
Illinois CancerCare-Pekin
Pekin, Illinois, 61554
Status
Address
Illinois CancerCare-Peoria
Peoria, Illinois, 61615
Status
Address
Illinois CancerCare-Peru
Peru, Illinois, 61354
Status
Address
Illinois CancerCare-Princeton
Princeton, Illinois, 61356
Status
Address
Elkhart Clinic
Elkhart, Indiana, 46514-2098
Status
Address
Michiana Hematology Oncology PC-Elkhart
Elkhart, Indiana, 46514
Status
Address
Elkhart General Hospital
Elkhart, Indiana, 46515
Status
Address
Indiana University/Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202
Status
Address
Community Howard Regional Health
Kokomo, Indiana, 46904
Status
Address
IU Health La Porte Hospital
La Porte, Indiana, 46350
Status
Address
Michiana Hematology Oncology PC-Mishawaka
Mishawaka, Indiana, 46545
Status
Address
Saint Joseph Regional Medical Center-Mishawaka
Mishawaka, Indiana, 46545
Status
Address
Michiana Hematology Oncology PC-Plymouth
Plymouth, Indiana, 46563
Status
Address
Reid Health
Richmond, Indiana, 47374
Status
Address
Memorial Hospital of South Bend
South Bend, Indiana, 46601
Status
Address
South Bend Clinic
South Bend, Indiana, 46617
Status
Address
Northern Indiana Cancer Research Consortium
South Bend, Indiana, 46628
Status
Address
Michiana Hematology Oncology PC-Westville
Westville, Indiana, 46391
Status
Address
Mary Greeley Medical Center
Ames, Iowa, 50010
Status
Address
McFarland Clinic - Ames
Ames, Iowa, 50010
Status
Address
University of Iowa Healthcare Cancer Services Quad Cities
Bettendorf, Iowa, 52722
Status
Address
McFarland Clinic - Boone
Boone, Iowa, 50036
Status
Address
Mercy Hospital
Cedar Rapids, Iowa, 52403
Status
Address
Oncology Associates at Mercy Medical Center
Cedar Rapids, Iowa, 52403
Status
Address
Mercy Cancer Center-West Lakes
Clive, Iowa, 50325
Status
Address
UI Health Care Mission Cancer and Blood - West Des Moines Clinic
Clive, Iowa, 50325
Status
Address
Iowa Methodist Medical Center
Des Moines, Iowa, 50309
Status
Address
Iowa-Wide Oncology Research Coalition NCORP
Des Moines, Iowa, 50309
Status
Address
UI Health Care Mission Cancer and Blood - Des Moines Clinic
Des Moines, Iowa, 50309
Status
Address
Mercy Medical Center - Des Moines
Des Moines, Iowa, 50314
Status
Address
UI Health Care Mission Cancer and Blood - Laurel Clinic
Des Moines, Iowa, 50314
Status
Address
Iowa Lutheran Hospital
Des Moines, Iowa, 50316
Status
Address
University of Iowa/Holden Comprehensive Cancer Center
Iowa City, Iowa, 52242
Status
Address
McFarland Clinic - Jefferson
Jefferson, Iowa, 50129
Status
Address
McFarland Clinic - Marshalltown
Marshalltown, Iowa, 50158
Status
Address
Siouxland Regional Cancer Center
Sioux City, Iowa, 51101
Status
Address
Mercy Medical Center-Sioux City
Sioux City, Iowa, 51102
Status
Address
Saint Luke's Regional Medical Center
Sioux City, Iowa, 51104
Status
Address
Methodist West Hospital
West Des Moines, Iowa, 50266-7700
Status
Address
Mercy Medical Center-West Lakes
West Des Moines, Iowa, 50266
Status
Address
Newman Regional Health
Emporia, Kansas, 66801
Status
Address
Saint Catherine Hospital
Garden City, Kansas, 67846
Status
Address
Saint Rose Ambulatory and Surgery Center
Great Bend, Kansas, 67530
Status
Address
HaysMed
Hays, Kansas, 67601
Status
Address
University of Kansas Cancer Center-West
Kansas City, Kansas, 66112
Status
Address
University of Kansas Cancer Center
Kansas City, Kansas, 66160
Status
Address
The University of Kansas Cancer Center - Olathe
Olathe, Kansas, 66061
Status
Address
Menorah Medical Center
Overland Park, Kansas, 66209
Status
Address
University of Kansas Cancer Center-Overland Park
Overland Park, Kansas, 66210
Status
Address
Saint Luke's South Hospital
Overland Park, Kansas, 66213
Status
Address
Mercy Hospital Pittsburg
Pittsburg, Kansas, 66762
Status
Address
Kansas City NCI Community Oncology Research Program
Prairie Village, Kansas, 66208
Status
Address
Salina Regional Health Center
Salina, Kansas, 67401
Status
Address
University of Kansas Health System Saint Francis Campus
Topeka, Kansas, 66606
Status
Address
Cancer Center of Kansas - Wichita
Wichita, Kansas, 67214
Status
Address
Oncology Hematology Care Inc-Crestview
Crestview Hills, Kentucky, 41017
Status
Address
Baptist Health Hardin
Elizabethtown, Kentucky, 42701
Status
Address
Baptist Health Lexington
Lexington, Kentucky, 40503
Status
Address
Ochsner Health Center-Summa
Baton Rouge, Louisiana, 70809
Status
Address
Ochsner Medical Center Jefferson
New Orleans, Louisiana, 70121
Status
Address
Bixby Medical Center
Adrian, Michigan, 49221
Status
Address
Hickman Cancer Center
Adrian, Michigan, 49221
Status
Address
Michigan Cancer Research Consortium NCORP
Ann Arbor, Michigan, 48106
Status
Address
Trinity Health Saint Joseph Mercy Hospital Ann Arbor
Ann Arbor, Michigan, 48106
Status
Address
Bronson Battle Creek
Battle Creek, Michigan, 49017
Status
Address
Corewell Health Dearborn Hospital
Dearborn, Michigan, 48124
Status
Address
Henry Ford Health Saint John Hospital
Detroit, Michigan, 48236
Status
Address
OSF Saint Francis Hospital and Medical Group
Escanaba, Michigan, 49829
Status
Address
Genesys Hurley Cancer Institute
Flint, Michigan, 48503
Status
Address
Hurley Medical Center
Flint, Michigan, 48503
Status
Address
Cancer Research Consortium of West Michigan NCORP
Grand Rapids, Michigan, 49503
Status
Address
Corewell Health Grand Rapids Hospitals - Butterworth Hospital
Grand Rapids, Michigan, 49503
Status
Address
Trinity Health Grand Rapids Hospital
Grand Rapids, Michigan, 49503
Status
Address
Allegiance Health
Jackson, Michigan, 49201
Status
Address
University of Michigan Health - Sparrow Lansing
Lansing, Michigan, 48912
Status
Address
Trinity Health Saint Mary Mercy Livonia Hospital
Livonia, Michigan, 48154
Status
Address
Mercy Memorial Hospital
Monroe, Michigan, 48162
Status
Address
Toledo Clinic Cancer Centers-Monroe
Monroe, Michigan, 48162
Status
Address
Trinity Health Muskegon Hospital
Muskegon, Michigan, 49444
Status
Address
Corewell Health Lakeland Hospitals - Niles Hospital
Niles, Michigan, 49120
Status
Address
Trinity Health Saint Joseph Mercy Oakland Hospital
Pontiac, Michigan, 48341
Status
Address
Lake Huron Medical Center
Port Huron, Michigan, 48060
Status
Address
Corewell Health Reed City Hospital
Reed City, Michigan, 49677
Status
Address
MyMichigan Medical Center Saginaw
Saginaw, Michigan, 48601
Status
Address
Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
Saint Joseph, Michigan, 49085
Status
Address
Corewell Health Lakeland Hospitals - Saint Joseph Hospital
Saint Joseph, Michigan, 49085
Status
Address
Munson Medical Center
Traverse City, Michigan, 49684
Status
Address
Henry Ford Health Warren Hospital
Warren, Michigan, 48093
Status
Address
Fairview Ridges Hospital
Burnsville, Minnesota, 55337
Status
Address
Mercy Hospital
Coon Rapids, Minnesota, 55433
Status
Address
Essentia Health Cancer Center
Duluth, Minnesota, 55805
Status
Address
Essentia Health Saint Mary's Medical Center
Duluth, Minnesota, 55805
Status
Address
Miller-Dwan Hospital
Duluth, Minnesota, 55805
Status
Address
Fairview Southdale Hospital
Edina, Minnesota, 55435
Status
Address
Unity Hospital
Fridley, Minnesota, 55432
Status
Address
Hutchinson Area Health Care
Hutchinson, Minnesota, 55350
Status
Address
Minnesota Oncology Hematology PA-Maplewood
Maplewood, Minnesota, 55109
Status
Address
Saint John's Hospital - Healtheast
Maplewood, Minnesota, 55109
Status
Address
Abbott-Northwestern Hospital
Minneapolis, Minnesota, 55407
Status
Address
Hennepin County Medical Center
Minneapolis, Minnesota, 55415
Status
Address
Health Partners Inc
Minneapolis, Minnesota, 55454
Status
Address
New Ulm Medical Center
New Ulm, Minnesota, 56073
Status
Address
North Memorial Medical Health Center
Robbinsdale, Minnesota, 55422
Status
Address
Mayo Clinic in Rochester
Rochester, Minnesota, 55905
Status
Address
Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, 55416
Status
Address
Park Nicollet Clinic - Saint Louis Park
Saint Louis Park, Minnesota, 55416
Status
Address
Regions Hospital
Saint Paul, Minnesota, 55101
Status
Address
United Hospital
Saint Paul, Minnesota, 55102
Status
Address
Saint Francis Regional Medical Center
Shakopee, Minnesota, 55379
Status
Address
Lakeview Hospital
Stillwater, Minnesota, 55082
Status
Address
Ridgeview Medical Center
Waconia, Minnesota, 55387
Status
Address
Rice Memorial Hospital
Willmar, Minnesota, 56201
Status
Address
Minnesota Oncology Hematology PA-Woodbury
Woodbury, Minnesota, 55125
Status
Address
Cox Cancer Center Branson
Branson, Missouri, 65616
Status
Address
Mercy Cancer Center - Cape Girardeau
Cape Girardeau, Missouri, 63703
Status
Address
MU Health - University Hospital/Ellis Fischel Cancer Center
Columbia, Missouri, 65212
Status
Address
Centerpoint Medical Center LLC
Independence, Missouri, 64057
Status
Address
MU Health Care Goldschmidt Cancer Center
Jefferson City, Missouri, 65109
Status
Address
Mercy Hospital Joplin
Joplin, Missouri, 64804
Status
Address
University Health Truman Medical Center
Kansas City, Missouri, 64108
Status
Address
Saint Luke's Hospital of Kansas City
Kansas City, Missouri, 64111
Status
Address
Heartland Hematology and Oncology Associates Incorporated
Kansas City, Missouri, 64118
Status
Address
The University of Kansas Cancer Center-South
Kansas City, Missouri, 64131
Status
Address
Research Medical Center
Kansas City, Missouri, 64132
Status
Address
University of Kansas Cancer Center - North
Kansas City, Missouri, 64154
Status
Address
University of Kansas Cancer Center - Lee's Summit
Lee's Summit, Missouri, 64064
Status
Address
Saint Luke's East - Lee's Summit
Lee's Summit, Missouri, 64086
Status
Address
Liberty Hospital
Liberty, Missouri, 64068
Status
Address
Mercy Clinic-Rolla-Cancer and Hematology
Rolla, Missouri, 65401
Status
Address
Phelps Health Delbert Day Cancer Institute
Rolla, Missouri, 65401
Status
Address
Heartland Regional Medical Center
Saint Joseph, Missouri, 64506
Status
Address
Saint Louis Cancer and Breast Institute-South City
Saint Louis, Missouri, 63109
Status
Address
Washington University School of Medicine
Saint Louis, Missouri, 63110
Status
Address
Missouri Baptist Medical Center
Saint Louis, Missouri, 63131
Status
Address
Mercy Hospital Saint Louis
Saint Louis, Missouri, 63141
Status
Address
Cancer Research for the Ozarks NCORP
Springfield, Missouri, 65804
Status
Address
Mercy Hospital Springfield
Springfield, Missouri, 65804
Status
Address
CoxHealth South Hospital
Springfield, Missouri, 65807
Status
Address
Billings Clinic Cancer Center
Billings, Montana, 59101
Status
Address
Saint Vincent Healthcare
Billings, Montana, 59101
Status
Address
Montana Cancer Consortium NCORP
Billings, Montana, 59102
Status
Address
Bozeman Health Deaconess Hospital
Bozeman, Montana, 59715
Status
Address
Saint James Community Hospital and Cancer Treatment Center
Butte, Montana, 59701
Status
Address
Benefis Sletten Cancer Institute
Great Falls, Montana, 59405
Status
Address
Saint Peter's Community Hospital
Helena, Montana, 59601
Status
Address
Logan Health Medical Center
Kalispell, Montana, 59901
Status
Address
Saint Patrick Hospital - Community Hospital
Missoula, Montana, 59802
Status
Address
Nebraska Cancer Research Center
Lincoln, Nebraska, 68510
Status
Address
Missouri Valley Cancer Consortium
Omaha, Nebraska, 68106
Status
Address
Nebraska Methodist Hospital
Omaha, Nebraska, 68114
Status
Address
Alegent Health Immanuel Medical Center
Omaha, Nebraska, 68122
Status
Address
Alegent Health Bergan Mercy Medical Center
Omaha, Nebraska, 68124
Status
Address
Alegent Health Lakeside Hospital
Omaha, Nebraska, 68130
Status
Address
Creighton University Medical Center
Omaha, Nebraska, 68131
Status
Address
Cancer and Blood Specialists-Henderson
Henderson, Nevada, 89052
Status
Address
Comprehensive Cancer Centers of Nevada - Henderson
Henderson, Nevada, 89052
Status
Address
Las Vegas Cancer Center-Henderson
Henderson, Nevada, 89052
Status
Address
Comprehensive Cancer Centers of Nevada-Southeast Henderson
Henderson, Nevada, 89074
Status
Address
GenesisCare USA - Henderson
Henderson, Nevada, 89074
Status
Address
University Medical Center of Southern Nevada
Las Vegas, Nevada, 89102
Status
Address
Cancer and Blood Specialists-Shadow
Las Vegas, Nevada, 89106
Status
Address
Radiation Oncology Centers of Nevada Central
Las Vegas, Nevada, 89106
Status
Address
GenesisCare USA - Las Vegas
Las Vegas, Nevada, 89109
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
Las Vegas, Nevada, 89109
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-San Martin
Las Vegas, Nevada, 89113
Status
Address
Radiation Oncology Centers of Nevada Southeast
Las Vegas, Nevada, 89119
Status
Address
Cancer Therapy and Integrative Medicine
Las Vegas, Nevada, 89121
Status
Address
Cancer and Blood Specialists-Tenaya
Las Vegas, Nevada, 89128
Status
Address
Comprehensive Cancer Centers of Nevada - Northwest
Las Vegas, Nevada, 89128
Status
Address
GenesisCare USA - Vegas Tenaya
Las Vegas, Nevada, 89128
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-Tenaya
Las Vegas, Nevada, 89128
Status
Address
Comprehensive Cancer Centers of Nevada-Summerlin
Las Vegas, Nevada, 89144
Status
Address
Las Vegas Cancer Center-Medical Center
Las Vegas, Nevada, 89148-2405
Status
Address
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, 89148
Status
Address
GenesisCare USA - Fort Apache
Las Vegas, Nevada, 89148
Status
Address
OptumCare Cancer Care at Fort Apache
Las Vegas, Nevada, 89148
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
Las Vegas, Nevada, 89149
Status
Address
Comprehensive Cancer Centers of Nevada - Central Valley
Las Vegas, Nevada, 89169
Status
Address
Nevada Cancer Research Foundation NCORP
Las Vegas, Nevada, 89169
Status
Address
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Lebanon, New Hampshire, 03756
Status
Address
Cooper Hospital University Medical Center
Camden, New Jersey, 08103
Status
Address
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903
Status
Address
University of New Mexico Cancer Center
Albuquerque, New Mexico, 87106
Status
Address
Memorial Medical Center-Las Cruces
Las Cruces, New Mexico, 88011
Status
Address
Montefiore Medical Center-Einstein Campus
Bronx, New York, 10461
Status
Address
Montefiore Medical Center - Moses Campus
Bronx, New York, 10467
Status
Address
Glens Falls Hospital
Glens Falls, New York, 12801
Status
Address
University of Rochester
Rochester, New York, 14642
Status
Address
Syracuse Veterans Administration Medical Center
Syracuse, New York, 13210
Status
Address
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599
Status
Address
Wayne Memorial Hospital
Goldsboro, North Carolina, 27534
Status
Address
Margaret R Pardee Memorial Hospital
Hendersonville, North Carolina, 28791
Status
Address
ECU Health Oncology Kinston
Kinston, North Carolina, 28501
Status
Address
Iredell Memorial Hospital
Statesville, North Carolina, 28677
Status
Address
Essentia Health Cancer Center-South University Clinic
Fargo, North Dakota, 58103
Status
Address
Strecker Cancer Center-Belpre
Belpre, Ohio, 45714
Status
Address
Toledo Clinic Cancer Centers-Bowling Green
Bowling Green, Ohio, 43402
Status
Address
Adena Regional Medical Center
Chillicothe, Ohio, 45601
Status
Address
Oncology Hematology Care Inc-Eden Park
Cincinnati, Ohio, 45202
Status
Address
Oncology Hematology Care Inc-Mercy West
Cincinnati, Ohio, 45211
Status
Address
Oncology Hematology Care Inc-Anderson
Cincinnati, Ohio, 45230
Status
Address
Oncology Hematology Care Inc-Kenwood
Cincinnati, Ohio, 45236
Status
Address
Oncology Hematology Care Inc-Blue Ash
Cincinnati, Ohio, 45242
Status
Address
Case Western Reserve University
Cleveland, Ohio, 44106
Status
Address
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210
Status
Address
Columbus Oncology and Hematology Associates Inc
Columbus, Ohio, 43214
Status
Address
Riverside Methodist Hospital
Columbus, Ohio, 43214
Status
Address
Columbus NCI Community Oncology Research Program
Columbus, Ohio, 43215
Status
Address
Grant Medical Center
Columbus, Ohio, 43215
Status
Address
The Mark H Zangmeister Center
Columbus, Ohio, 43219
Status
Address
Mount Carmel Health Center West
Columbus, Ohio, 43222
Status
Address
Doctors Hospital
Columbus, Ohio, 43228
Status
Address
Good Samaritan Hospital - Dayton
Dayton, Ohio, 45406
Status
Address
Miami Valley Hospital
Dayton, Ohio, 45409
Status
Address
Miami Valley Hospital North
Dayton, Ohio, 45415
Status
Address
Dayton NCI Community Oncology Research Program
Dayton, Ohio, 45459
Status
Address
Delaware Health Center-Grady Cancer Center
Delaware, Ohio, 43015
Status
Address
Delaware Radiation Oncology
Delaware, Ohio, 43015
Status
Address
Grady Memorial Hospital
Delaware, Ohio, 43015
Status
Address
Oncology Hematology Care Inc-Healthplex
Fairfield, Ohio, 45014
Status
Address
Blanchard Valley Hospital
Findlay, Ohio, 45840
Status
Address
Atrium Medical Center-Middletown Regional Hospital
Franklin, Ohio, 45005-1066
Status
Address
Wayne Hospital
Greenville, Ohio, 45331
Status
Address
Kettering Medical Center
Kettering, Ohio, 45429
Status
Address
Fairfield Medical Center
Lancaster, Ohio, 43130
Status
Address
Lancaster Radiation Oncology
Lancaster, Ohio, 43130
Status
Address
Lima Memorial Hospital
Lima, Ohio, 45804
Status
Address
Marietta Memorial Hospital
Marietta, Ohio, 45750
Status
Address
Toledo Clinic Cancer Centers-Maumee
Maumee, Ohio, 43537
Status
Address
Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
Maumee, Ohio, 43537
Status
Address
Knox Community Hospital
Mount Vernon, Ohio, 43050
Status
Address
Licking Memorial Hospital
Newark, Ohio, 43055
Status
Address
Newark Radiation Oncology
Newark, Ohio, 43055
Status
Address
Saint Charles Hospital
Oregon, Ohio, 43616
Status
Address
Toledo Clinic Cancer Centers-Oregon
Oregon, Ohio, 43616
Status
Address
Southern Ohio Medical Center
Portsmouth, Ohio, 45662
Status
Address
Springfield Regional Medical Center
Springfield, Ohio, 45504
Status
Address
ProMedica Flower Hospital
Sylvania, Ohio, 43560
Status
Address
Mercy Hospital of Tiffin
Tiffin, Ohio, 44883
Status
Address
Mercy Health - Saint Vincent Hospital
Toledo, Ohio, 43608
Status
Address
University of Toledo
Toledo, Ohio, 43614
Status
Address
Toledo Community Hospital Oncology Program CCOP
Toledo, Ohio, 43617
Status
Address
Mercy Health - Saint Anne Hospital
Toledo, Ohio, 43623
Status
Address
Toledo Clinic Cancer Centers-Toledo
Toledo, Ohio, 43623
Status
Address
Upper Valley Medical Center
Troy, Ohio, 45373
Status
Address
Fulton County Health Center
Wauseon, Ohio, 43567
Status
Address
Saint Ann's Hospital
Westerville, Ohio, 43081
Status
Address
Genesis Healthcare System Cancer Care Center
Zanesville, Ohio, 43701
Status
Address
Cancer Centers of Southwest Oklahoma Research
Lawton, Oklahoma, 73505
Status
Address
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104
Status
Address
Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, 74146
Status
Address
Clackamas Radiation Oncology Center
Clackamas, Oregon, 97015
Status
Address
Providence Milwaukie Hospital
Milwaukie, Oregon, 97222
Status
Address
Providence Newberg Medical Center
Newberg, Oregon, 97132
Status
Address
Providence Willamette Falls Medical Center
Oregon City, Oregon, 97045
Status
Address
Providence Portland Medical Center
Portland, Oregon, 97213
Status
Address
Providence Saint Vincent Medical Center
Portland, Oregon, 97225
Status
Address
Saint Luke's University Hospital-Bethlehem Campus
Bethlehem, Pennsylvania, 18015
Status
Address
Geisinger Medical Center
Danville, Pennsylvania, 17822
Status
Address
Geisinger Medical Center-Cancer Center Hazleton
Hazleton, Pennsylvania, 18201
Status
Address
Guthrie Medical Group PC-Robert Packer Hospital
Sayre, Pennsylvania, 18840
Status
Address
Geisinger Medical Group
State College, Pennsylvania, 16801
Status
Address
Geisinger Wyoming Valley/Henry Cancer Center
Wilkes-Barre, Pennsylvania, 18711
Status
Address
UPMC Susquehanna
Williamsport, Pennsylvania, 17701
Status
Address
Prisma Health Cancer Institute - Spartanburg
Boiling Springs, South Carolina, 29316
Status
Address
McLeod Regional Medical Center
Florence, South Carolina, 29506
Status
Address
Prisma Health Cancer Institute - Butternut
Greenville, South Carolina, 29605
Status
Address
Prisma Health Cancer Institute - Faris
Greenville, South Carolina, 29605
Status
Address
Prisma Health Greenville Memorial Hospital
Greenville, South Carolina, 29605
Status
Address
Prisma Health Cancer Institute - Eastside
Greenville, South Carolina, 29615
Status
Address
Prisma Health Cancer Institute - Greer
Greer, South Carolina, 29650
Status
Address
Prisma Health Cancer Institute - Seneca
Seneca, South Carolina, 29672
Status
Address
Rapid City Regional Hospital
Rapid City, South Dakota, 57701
Status
Address
Baylor University Medical Center
Dallas, Texas, 75246
Status
Address
Houston Methodist Hospital
Houston, Texas, 77030
Status
Address
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229
Status
Address
American Fork Hospital / Huntsman Intermountain Cancer Center
American Fork, Utah, 84003
Status
Address
Sandra L Maxwell Cancer Center
Cedar City, Utah, 84720
Status
Address
Logan Regional Hospital
Logan, Utah, 84321
Status
Address
Intermountain Medical Center
Murray, Utah, 84107
Status
Address
McKay-Dee Hospital Center
Ogden, Utah, 84403
Status
Address
Utah Valley Regional Medical Center
Provo, Utah, 84604
Status
Address
Saint George Regional Medical Center
Saint George, Utah, 84770
Status
Address
Utah Cancer Specialists-Salt Lake City
Salt Lake City, Utah, 84106
Status
Address
LDS Hospital
Salt Lake City, Utah, 84143
Status
Address
Southwestern Vermont Medical Center
Bennington, Vermont, 05201
Status
Address
Fredericksburg Oncology Inc
Fredericksburg, Virginia, 22401
Status
Address
PeaceHealth Southwest Medical Center
Vancouver, Washington, 98664
Status
Address
Compass Oncology Vancouver
Vancouver, Washington, 98684
Status
Address
Edwards Comprehensive Cancer Center
Huntington, West Virginia, 25701
Status
Address
Marshfield Clinic-Chippewa Center
Chippewa Falls, Wisconsin, 54729
Status
Address
HSHS Sacred Heart Hospital
Eau Claire, Wisconsin, 54701
Status
Address
Marshfield Clinic Cancer Center at Sacred Heart
Eau Claire, Wisconsin, 54701
Status
Address
Green Bay Oncology at Saint Vincent Hospital
Green Bay, Wisconsin, 54301-3526
Status
Address
Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, 54301
Status
Address
Saint Vincent Hospital Cancer Center at Saint Mary's
Green Bay, Wisconsin, 54303
Status
Address
University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, 53792
Status
Address
Holy Family Memorial Hospital
Manitowoc, Wisconsin, 54221
Status
Address
Marshfield Medical Center-Marshfield
Marshfield, Wisconsin, 54449
Status
Address
Marshfield Medical Center
Marshfield, Wisconsin, 54449
Status
Address
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
Status
Address
Marshfield Medical Center - Minocqua
Minocqua, Wisconsin, 54548
Status
Address
Cancer Center of Western Wisconsin
New Richmond, Wisconsin, 54017
Status
Address
Saint Vincent Hospital Cancer Center at Oconto Falls
Oconto Falls, Wisconsin, 54154
Status
Address
Aspirus Cancer Care - James Beck Cancer Center
Rhinelander, Wisconsin, 54501
Status
Address
Saint Mary's Hospital
Rhinelander, Wisconsin, 54501
Status
Address
Marshfield Medical Center-Rice Lake
Rice Lake, Wisconsin, 54868
Status
Address
HSHS Saint Nicholas Hospital
Sheboygan, Wisconsin, 53081
Status
Address
Aspirus Cancer Care - Stevens Point
Stevens Point, Wisconsin, 54481
Status
Address
Marshfield Clinic-Wausau Center
Wausau, Wisconsin, 54401
Status
Address
Ascension Saint Clare's Hospital
Weston, Wisconsin, 54476
Status
Address
Marshfield Medical Center - Weston
Weston, Wisconsin, 54476
Status
Address
Marshfield Clinic - Wisconsin Rapids Center
Wisconsin Rapids, Wisconsin, 54494
Status
Address
Rocky Mountain Oncology
Casper, Wyoming, 82609
Status
Address
Welch Cancer Center
Sheridan, Wyoming, 82801
International Sites
Status
Address
Arthur J E Child Comprehensive Cancer Centre
Calgary, Alberta, T2N 5G2
Status
Address
BCCA-Vancouver Cancer Centre
Vancouver, British Columbia, V5Z 4E6
Status
Address
The Vitalite Health Network - Dr Leon Richard Oncology Centre
Moncton, New Brunswick, E1C 8X3
Status
Address
QEII Health Sciences Centre/Nova Scotia Health Authority
Halifax, Nova Scotia, B3H 2Y9
Status
Address
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, L8V 5C2
Status
Address
Waterloo Regional Health Network
Kitchener, Ontario, N2G 1G3
Status
Address
Ottawa Hospital and Cancer Center-General Campus
Ottawa, Ontario, K1H 8L6
Status
Address
University Health Network-Princess Margaret Hospital
Toronto, Ontario, M5G 2M9
Status
Address
CHUM - Hopital Notre-Dame
Montreal, Quebec, H2L 4M1
Status
Address
CHUM - Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, H2X 3E4
Status
Address
Allan Blair Cancer Centre
Regina, Saskatchewan, S4T 7T1
Status
Address
Saskatoon Cancer Centre
Saskatoon, Saskatchewan, S7N 4H4
